Insider trading · Q3 2026 · CIK 1609809

Seres Therapeutics, Inc. (MCRB) insider trading.

In Q3 2026, insiders at Seres Therapeutics, Inc. reported 8 non-derivative transactions on 19 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $2K.

Transactions
8
Purchases (P)
0
Sales (S)
4
Net shares, P minus S
-490
Insiders
4
Last filed
2026-08-18

Insiders

InsiderRelationshipTransactionsBuysSales
DesRosier ThomasOfficer · See Remarks201
Henn Matthew ROfficer · See Remarks201
Shaff Eric D.Director201
Brady KellyOfficer · See Remarks201

Transactions

8 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-17DesRosier ThomasS (D)82$4.558,117Form 4
2026-08-17Henn Matthew RS (D)81$4.557,995Form 4
2026-08-17Shaff Eric D.S (D)263$4.5512,499Form 4
2026-08-17Brady KellyS (D)64$4.558,679Form 4
2026-08-15DesRosier ThomasM (A)245—8,199Form 4
2026-08-15Henn Matthew RM (A)238—8,076Form 4
2026-08-15Shaff Eric D.M (A)722—12,762Form 4
2026-08-15Brady KellyM (A)181—8,743Form 4

Transaction codes in this quarter

Get MCRB insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1609809&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · MCRB company page · Seres Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Seres Therapeutics, Inc. (MCRB)?

In Q3 2026, insiders at Seres Therapeutics, Inc. reported 8 non-derivative transactions on 19 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $2K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Seres Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/mcrb.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.